Skip to main content Back to Top


Ribavirin Inhalation

Products Affected - Description

    • Virazole inhalation powder for solution, Bausch Health, 6 gram, 100 mL vial, 4 count, NDC 00187-0007-14
    • Ribavirin inhalation powder for solution, Zydus, 6 gram, 100 mL vial, 4 count, NDC 68382-0395-04

Reason for the Shortage

    • Bausch Health did not provide a reason for the shortage. Bausch Health discontinued the authorized generic in October 2022.
    • Cameron Pharmaceuticals was not available to provide information.
    • Zydus did not provide a reason for the shortage.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Bausch Health has Virazole inhalation 6 gram powder for solution on long-term back order and the company cannot estimate a release date.
    • Zydus has ribavirin inhalation 6 gram powder for solution available with short expiration dating. The company estimates additional product will be available in the second half of 2023.


Created May 23, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.



Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.